Abstract-Ventricular arrhythmias and contractile dysfunction are the main causes of death in human heart failure (HF).
H eart failure (HF), which affects more than two million Americans, is associated with high mortality as a result of contractile dysfunction (pump failure) or sudden death caused by ventricular arrhythmias. 1 The genesis of HF syndromes is complex and multifactorial, but altered cellular Ca 2ϩ regulation may be a final common pathway in both pump failure and arrhythmogenesis. [2] [3] [4] [5] Decreased Ca 2ϩ transients in HF reduce myofilament activation and depress contractility. 2 Although it is unknown why Ca 2ϩ transients are depressed, it is likely due to a decrease in sarcoplasmic reticulum (SR) Ca 2ϩ release or Ca 2ϩ influx via Ca 2ϩ current (I Ca ). Many, although not all, HF studies show that I Ca is unchanged. 3, 4, 6 Decreased SR Ca 2ϩ release could reflect either reduced SR Ca 2ϩ release channel sensitivity to I Ca 4 or reduced SR Ca 2ϩ content. Reduced SR Ca 2ϩ load can be caused by decreased SR Ca 2ϩ -ATPase (SERCA) and/or increased Na ϩ -Ca 2ϩ exchange (NaCaX), because these transporters compete for [Ca 2ϩ ] i during relaxation and diastole. 7 Moreover in HF, data indicate lower SERCA expression 8, 9 and increased NaCaX expression, 6, 10, 11 but direct assessment of SR Ca 2ϩ content in HF is limited. It
is also unclear what role altered NaCaX plays with respect to contractile dysfunction in HF. These issues are addressed here. Electrical reentry contributes to ventricular tachycardia (VT) in many pathophysiological states, but 3-dimensional mapping studies show that most fatal arrhythmias in HF initiate by a nonreentrant mechanism [12] [13] [14] [15] such as delayed afterdepolarizations (DADs) and early afterdepolarizations. 16, 17 This is true for 100% of VTs in human nonischemic cardiomyopathy (and 50% in ischemic cardiomyopathy). 18, 19 At normal action potential (AP) duration and heart rates, DADs may predominate over early afterdepolarizations. DADs, which are enhanced by ␤-adrenergic receptor (␤-AR) stimulation, 16 occur after AP repolarization and are initiated by spontaneous SR Ca 2ϩ release. This leads to activation of a Ca 2ϩ -activated transient inward current (I ti ), which has been proposed to be carried by any of the following different Ca 2ϩ -activated currents: (1) NaCaX current (I Na-Ca ), (2) Ca 2ϩ -activated chloride current (I Cl(Ca) ), or (3) a nonselective cationic current (I NS(Ca) ). 16,20 -22 The inward rectifying K current I K1 is crucial in stabilizing the resting membrane potential (E m ). Although I K1 is reduced in human HF, 23 it is unclear, especially from a quantitative standpoint, how this may destabilize resting E m and ultimately contribute to the genesis of DADs, triggered APs, and arrhythmogenesis in HF.
The goal of this study was to define molecular mechanisms underlying both arrhythmogenesis and contractile dysfunction in HF. Studies were performed in an arrhythmogenic rabbit HF model of combined aortic insufficiency and constriction. This rabbit HF model resembles human nonischemic HF in exhibiting marked left ventricular (LV) dilation and hypertrophy, severely reduced systolic function, moderately decreased ␤-AR density, and nonreentrant ventricular arrhythmias. 6, 13, 15, 24, 25 We previously found an increase in heart weight/body weight (by 80%), average myocyte size (89%), and LV end-diastolic diameter (41%). 6 LV fractional shortening is reduced by 36%, and isolated ventricular myocyte shortening is reduced by 30%. Greater than 10% of the HF rabbits die from sudden cardiac death, and during 24-hour Holter monitoring 90% of these animals show runs of nonsustained VT. 6 Three-dimensional mapping showed that these arrhythmias all initiate by a nonreentrant mechanism. 13 Thus, this arrhythmogenic rabbit HF model exhibits the contractile and electrophysiological alterations seen in human HF at the critical stage at which arrhythmogenesis and contractile dysfunction are manifest. This provides a unique opportunity for assessment of the underlying molecular mechanisms.
Here we demonstrate that I Na/Ca is the current producing DADs in HF and that upregulated NaCaX, reduced I K1 , and residual ␤-AR responsiveness work together to greatly increase arrhythmogenesis in HF. We also show that NaCaX plays a central role in mediating both arrhythmogenesis and contractile dysfunction in HF (by lowering SR Ca 2ϩ load).
Materials and Methods

Rabbit HF Model and Myocyte Isolation
In New Zealand White rabbits (Ϸ3.5 kg), HF was induced by aortic insufficiency and 2 to 4 weeks later by thoracic aortic constriction (both induced during ketamine/pentobarbital anesthesia) as previously described. 6 Progression was assessed by 2-dimensional echocardiography. 6 Rabbits were studied 9.5Ϯ2.0 months after aortic constriction, when the LV end-systolic dimension exceeded 1.20 cm. 6 At this stage, intravenous infusion of isoproterenol (1 g/kg per minute) for 3 minutes was performed in conscious control and HF rabbits with monitoring of the surface ECG. Protocols were approved by the University of Illinois at Chicago Animal Studies Committee. Rabbit LV myocytes were isolated as described, 6 with back flow across the incompetent aortic valve in HF rabbits blocked by a balloon-tipped catheter inflated in the LV outflow tract.
Contraction [Ca 2؉ ] i and Patch Clamp
Myocyte shortening was measured by video edge detection and [Ca 2ϩ ] i was measured by indo-1 and fluo-3 epifluorescence. 26, 27 The normal Tyrode's (NT) solution contained (in mmol/L) NaCl 140, KCl 4, MgCl 2 1, CaCl 2 2, glucose 10, and HEPES 5 (pH 7.4). Myocytes were studied at 23°C or 37°C.
Some myocytes were field-stimulated in NT ( Figure 1B ). Perforated patch voltage clamp was done in experiments illustrated in Figures 1C through 1F Figure 3C , sharper pipettes (5 to 20 M⍀) contained (in mmol/L) potassium aspartate 120, KCl 8, NaCl 7, HEPES 10, MgCl 2 1, Mg-ATP 5, Li-GTP 0.3, and K 5 -indo-1 0.05 (pH 7.2) at 37°C, and cells were preloaded with indo-1-acetoxymethyl ester. 22 I Na/Ca integral (in C/F) was multiplied by 71.8 molϫF/(CϫL cytosol), 28 yielding SR Ca 2ϩ load in mol/L cytosol. Cells were either voltage clamped in NT ( Figure 3C ), voltage clamped in NT with 6 mmol/L cesium replacing potassium ( Figures 1C through 1F , 2B, 2C, 3A, 3B, and 3D), voltage clamped in NT plus 0.3 mmol/L cadmium ( Figures 5B and 5C ), or current clamped in NT ( Figures  2A, 4 , 5A, 6A, and 6B [right]). Membrane capacitance was measured from responses to 5-mV hyperpolarizing and depolarizing pulses. 29 SR Ca 2ϩ load was varied before caffeine application by changing AP frequency, pulse number, or rest interval. For testing I ti effects on E m , we applied a synthetic current waveform chosen to match I ti s measured in rabbit myocytes. 22 This injected pseudo-I ti was varied in amplitude. Data are meanϮSE, and statistical significance was based on PϽ0.05 (Student t test, ANOVA, and 2 ). An expanded Materials and Methods section can be found in the online data supplement available at http://www.circresaha.org. Figure 1A shows cardiac enlargement and spontaneous nonsustained VT that are typical of HF rabbits used in the present study. Isolated LV myocytes from HF rabbit ( Figure 1B ) also show spontaneous closely coupled aftercontractions and Ca 2ϩ transients after 1-Hz stimulation at 37°C, seen only after isoproterenol 1 mol/L (blockable by 1 mol/L propranolol). All HF myocytes (7 of 7 from 5 hearts) exhibited such aftercontractions, versus a minority of control myocytes with this protocol (2 of 7 from 3 hearts; PϽ0.01). Thus, HF rabbit myocytes exhibit enhanced susceptibility to aftercontractions. As discussed elsewhere, control myocytes have safety factors that limit the ability of a spontaneous SR Ca 2ϩ release to trigger an AP. 22 
Results
Ca
2؉ Transients, I Ca , and ␤-Adrenergic Stimulation
In voltage-clamped HF myocytes, Ca 2ϩ transients (⌬[Ca 2ϩ ] i ) were smaller than control, but peak I Ca was unaltered ( Figures  1C and 1D ). This agrees with previous I Ca data in which Ca 2ϩ transients were prevented. 6 If the coupling between the L-type Ca 2ϩ channel and SR Ca 2ϩ release channel were altered in HF, SR Ca 2ϩ release would cause less Ca 2ϩ -dependent I Ca inactivation in HF. 4 However, we found no HF-associated change in time constants of I Ca inactivation ( fast or slow ) or fraction of inactivation in the fast phase ( Figure 1F ). Ca 2ϩ transients and I Ca were increased by exposure to isoproterenol in both control and HF myocytes ( Figures 1C and 1E ). Whereas the ␤-AR stimulation of I Ca in HF was significantly less than in control, the ⌬[Ca 2ϩ ] i response was comparable (65% in HF versus 78% in control). Thus, HF cells exhibit clear residual ␤-AR responsiveness, consistent with the progressive but incomplete ␤-AR downregulation seen both in human HF 30, 31 Figure 2B , bottom), indicating that I Na/Ca is functionally upregulated during dynamic Ca 2ϩ transients (confirming our data showing 2-fold increases in NaCaX mRNA, protein, and I Na/Ca , where [Ca 2ϩ ] i was clamped). 6 The enhanced inward I Na/Ca means that NaCaX must compete better with SERCA during twitch relaxation and diastole and thereby directly explains the reduced SR Ca 2ϩ and contractile dysfunction in HF (even if SERCA was relatively unchanged; see Discussion). . These Ca 2ϩ -activated inward currents in HF were carried entirely by I Na/Ca , because they were abolished by blocking NaCaX ( Figure 3C ) as in control. 29 Thus, I Cl(Ca) and I NS(Ca) do not contribute significantly to I ti s, and our preliminary data suggest that this is also true in human HF ventricular myocytes at 37°C (S.M.P., K.S., D.M.B., unpublished data, 2000). As such, the I Na/Ca (including I ti s) in Figure 3A can be integrated to evaluate the SR Ca 2ϩ load that was present at the moment the first spontaneous I ti occurred. Although I ti s in Figures 3A and 3B were seen only with isoproterenol, for a given depolarizing pulse, I ti s were more readily induced in HF than control (8 of 10 versus 3 of 9; PϽ0.05; for 10 mol/L isoproterenol, [Ca 2ϩ ] o ϭ2 mmol/L). We attribute this to the upregulated NaCaX and greater Ca 2ϩ influx while holding at ϩ50 mV. However, the crucial result is that the threshold SR Ca 2ϩ load for I ti induction was unchanged in HF ( Figure 3B) . A typical I ti removes 15 to 20 mol Ca 2ϩ /L cytosol from the cell (and SR). Thus, in cells in which SR Ca 2ϩ was driven to the highest levels (as in Figure 3A) , two or more I ti s were reproducibly observed and the second I ti brought the SR Ca 2ϩ load below threshold. At more modest SR Ca 2ϩ load (eg, Ϸ115 mol/L cytosol), a single I ti was sufficient to bring SR Ca 2ϩ load below threshold. If SR Ca 2ϩ load is low in HF myocyte and threshold SR Ca 2ϩ load for triggering an I ti is unaltered, how does it increase to produce I ti s? This paradox can be explained by sympathetic bursts, which stimulate the SERCA, 33 raising SR Ca 2ϩ load above threshold. This is supported by our findings above that ␤-AR activation significantly enhanced aftercontractions (in 100% of HF cells) and I ti s (in 80% of HF cells) by increasing SR Ca 2ϩ ( Figures 1B, 3A , and 3B) and also induced ventricular arrhythmias including nonsustained VT in 3 of 3 intact HF rabbits (versus 0 of 3 controls). This may also explain why sudden arrhythmic deaths are more common before end-stage HF, ie, before ␤-AR responsiveness is largely lost. 31, 34 Thus, some residual ␤-AR responsiveness may be critical in enabling the spontaneous SR Ca 2ϩ releases that trigger arrhythmias.
SR
⌬[Ca
2؉ ] i Required to Trigger an AP
If the threshold SR Ca 2ϩ for release is unchanged, perhaps the increased propensity for triggered arrhythmias in HF reflects the way the cell responds to a given SR Ca 2ϩ release. Indeed, in HF peak I Na/Ca during spontaneous I ti s was larger, even for a comparable amount of net charge moved (integrated I ti , Figure 3D ). This higher peak I ti agrees with greater inward I Na/Ca versus [Ca 2ϩ ] i during caffeine-induced contractions (Figure 2B ). This is expected to cause greater depolarization (⌬E m ) in HF for a given ⌬[Ca 2ϩ ] i , bringing E m closer to threshold to fire an AP.
We tested this quantitatively by measuring E m in currentclamped myocytes and applying caffeine to produce controlled ⌬[Ca 2ϩ ] i . Figures 4A and 4B show APs, twitch ⌬[Ca 2ϩ ] i and subsequent caffeine-induced Ca 2ϩ transients, and the associated caffeine-induced afterdepolarizations (or cDADs). 22 In HF, the AP duration was 19% longer and the increase in twitch ⌬[Ca 2ϩ ] i with frequency was blunted (as in human HF). 2 At low frequency and SR Ca 2ϩ load, cDADs are subthreshold. As SR Ca 2ϩ increases with frequency, we can measure a threshold for AP induction with respect to ⌬[Ca 2ϩ ] i and ⌬E m ( Figure 4A ). As for I ti , three different Ca 2ϩ -activated currents have been suggested to play a role in DADs (I Na/Ca , I Cl(Ca) , and I NS(Ca) ). Figure 4C shows that cDADs in HF cells are virtually abolished when I Na/Ca is blocked by removing extracellular Na ϩ and Ca 2ϩ (which should still allow both I Cl(Ca) and I NS(Ca) ). Note also that [Ca 2ϩ ] i decline is drastically slowed by blocking NaCaX, which is the main means of Ca 2ϩ removal in the presence of caffeine. 22, 29 Blocking I Cl(Ca) with niflumate hardly affected cDADs, which confirms that DADs are driven almost exclusively by I Na/Ca . The same approach can be used to induce cDADs and APs in human HF ventricular myocytes (S.M.P., K.S., D.M.B., unpublished observations, 2000). Figure 5A shows quantitatively that in HF versus control, a given ⌬[Ca 2ϩ ] i produces greater depolarization ] i is required for a cDAD to trigger an AP in HF (as expected from the increased I Na/Ca ). However, E m might also respond differently to a given I Na/Ca in HF (eg, as a result of other currents).
Altered Potassium Currents: Ca 2؉ -Independent Changes
Figures 5B and 5C show that in HF rabbits, transient outward and inward rectifier potassium currents (I to and I K1 ) were reduced significantly (by 34% and 49%, respectively), as has been reported in human HF. 23 Notably, the 49% reduction in I K1 was observed at all E m values and would tend to destabilize the resting E m ( Figure 5C, inset) . Thus, a given I ti might produce greater depolarization in the face of reduced I K1 . Figure 6A tests this expectation quantitatively using current injections of varying amplitude, with time courses that simulate real I ti s (but without changing [Ca 2ϩ ] i or Ca 2ϩ -activated currents). Increasing the amplitude of these pseudo-I ti s results in larger depolarization, 22 and with sufficient injected charge (ie, threshold charge) an AP is triggered. In HF, any given pseudo-I ti produces greater depolarization (small points and curves in Figure 6A ). More importantly, the threshold current integral (or charge) to trigger an AP is Ϸ25% smaller in HF (large squares; PϽ0.05).
To test whether the reduction in I K1 in HF would be quantitatively sufficient to explain the Ca 2ϩ -independent shifts seen in Figure 6A , we partially blocked I K1 in control cells ( Figure 6B ) to see whether that could mimic the shift seen in HF. Barium blocked I K1 with an IC 50 of 5 to 15 mol/L (depending slightly on E m ). Subthreshold pseudo-I ti s in a representative control cell are shown in the absence and ] i for an AP is reduced 46% in HF (Ⅲ). B, I to during 300-ms steps from E m ϭϪ60 to Ϫ20 -ϩ80 mV. Peak currents are shown, but results are similar for the inactivatingor 4-aminopyridine-sensitive component (3 mmol/L, nϭ6 HF and 6 control). C, I K1 during 500-ms steps from E m ϭϪ30 to Ϫ120 -ϩ40 mV was blockable by 1 mmol/L barium (nϭ6 HF and 6 control). I to and I K1 were measured in NT with 0.3 mmol/L CdCl 2 at 23°C (*PϽ0.05). presence of 3 mol/L barium. Barium shifted the relation just as seen in HF. Mean barium effects were to shift doubling charge from 0.45Ϯ0.06 to 0.21Ϯ0.03 C/F at 3 mol/L barium and to 0.157Ϯ0.013 C/F at 5 mol/L barium (nϭ14, 4, and 4, PϽ0.05). Therefore, the 49% I K1 reduction in HF is sufficient to completely and quantitatively explain the greater depolarization for a given current injection in HF ( Figure 6A ).
Discussion
We conclude (Figure 7 ) that three major factors conspire to greatly enhance the propensity for arrhythmogenesis in HF: (1) increased NaCaX (providing more arrhythmogenic I ti for any given SR Ca 2ϩ release), (2) reduced I K1 (allowing greater depolarization for any given I ti ), and (3) residual ␤-AR responsiveness (required to raise the low SR Ca 2ϩ load in HF to the point at which more spontaneous SR Ca 2ϩ release occurs).
The current(s) responsible for DADs has been controversial, but we have shown that I Na/Ca is the current that underlies I ti and DAD in myocytes from HF rabbits at 37°C (similar to I ti data at 20°C in human HF). 35 Although other Ca 2ϩ -activated currents may occur, particularly in other species or cell types in the heart, they do not contribute quantitatively to I ti or DADs under physiological conditions in ventricular myocytes from rabbits (and likely, humans) with HF. Moreover, the 2-fold upregulation of NaCaX in rabbit and human HF indicates that larger I ti s and DADs would be expected for a given ⌬[Ca 2ϩ ] i (and we have demonstrated this quantitatively for I ti s and cDADs).
I K1 was decreased by 49% in HF rabbit myocytes (similar to human HF 23 ) . No quantitative functional link has previously been developed for I K1 in arrhythmogenesis in HF. We show that the reduction of I K1 is quantitatively sufficient to explain the greater depolarization seen for a given inward current (Ca 2ϩ -independent pseudo-I ti ) in HF. Thus, reduced I K1 in HF is of paramount importance in lowering the threshold for an I ti -triggered AP. Although I Na/Ca is almost entirely responsible for I ti s (in control and HF), reduced I K1 in HF allows that I Na/Ca to produce greater depolarization. Based on the HF shifts in Figures 5A and 6A and release and aftercontractions after isoproterenol (although an IC 50 for isoproterenol was not determined). Moreover, in very-late-stage human HF, there are fewer sudden arrhythmic deaths, and this corresponds to the time when there is more complete loss of ␤-AR responsiveness. 31, 34 At this stage as pump failure continues, arrhythmias may be less likely because the SR Ca 2ϩ load never gets high enough for spontaneous SR Ca 2ϩ release (although elevated NaCaX and reduced I K1 may persist).
The higher NaCaX in HF also contributes to contractile dysfunction by competing with the SERCA and unloading the SR. In this rabbit HF model, we had not detected alteration in SERCA on Northern or Western blots, but function in HF myocytes appeared to be decreased by up to 24%. 6 This minimal SERCA alteration (compared with some HF models) illustrates that the large increase in NaCaX alone may be sufficient to unload the SR and hence cause contractile dysfunction. Of course, any reduction in SERCA versus NaCaX would further shift this balance and lower the SR Ca 2ϩ load more severely. This demonstrates a novel dual role for elevated NaCaX as a central causative factor in both arrhythmogenesis and contractile dysfunction. This also relates to human HF, in which Hasenfuss et al 11 found that 44% of failing human hearts (their group I, with preserved diastolic function) had Ϸ2-fold increase in NaCaX protein expression and Ϸ25% decrease in SERCA, which is very similar to our HF rabbits. Additional reduction of SERCA seen in HF Pogwizd et al Na ؉ -Ca 2؉ Exchange, I K1 , and DADS in Heart Failurepatients with diastolic dysfunction slows twitch relaxation and further decreases SR Ca 2ϩ load and systolic function. 11 Although increased NaCaX expression in HF could enhance Ca 2ϩ entry (via outward I Na/Ca ), 36, 37 this seems likely only for very prolonged APs in HF. This effect was not seen here.
This work and novel paradigm (Figure 7 ) raise the issue of molecular targets for therapeutics in HF. Inhibiting NaCaX might improve contractile function and acutely limit arrhythmias but is dangerous because of the crucial role of NaCaX in removing the Ca 2ϩ , which enters at each beat via I Ca . Partially blocking NaCaX could worsen cellular Ca 2ϩ overload, ultimately causing spontaneous SR Ca 2ϩ release and arrhythmia (as seen with Na/K-ATPase inhibition in digitalis toxicity). Such spontaneous SR Ca 2ϩ release can seriously exacerbate contractile dysfunction by desynchronizing contractions in cells, which are in series with each other, 7 even if arrhythmogenic I Na/Ca was less. Increasing SERCA (eg, by gene transfer or phospholamban inhibition) 38, 39 would help the SERCA compete better with NaCaX to maintain more normal SR Ca 2ϩ load and improve contractile function, but it may increase the propensity for Ca 2ϩ overload and DADs. SR Ca 2ϩ -pump stimulation could be the reason why phosphodiesterase inhibitory inotropes (which increase cAMP) are proarrhythmic and increase mortality. 40 Blocking ␤-ARs could prevent spontaneous SR Ca 2ϩ release by reducing the increment in SR Ca 2ϩ load (induced by adrenergic surges). This would account for the effectiveness of ␤-AR blockers in reducing sudden death in HF. 41 Enhancing I K1 to stabilize resting E m could also be beneficial but could also reduce excitability, propagation rate, and AP duration. Overall, a balance must be sought to enhance SERCA function without increasing arrhythmogenesis.
HF and its etiologies are extremely complex, but altered myocyte Ca 2ϩ regulation and ion channels appear to be crucial in the final common pathways of sudden death and pump failure. The data here support a novel paradigm of three key factors (increased NaCaX, reduced I K1 , and residual ␤-adrenergic responsiveness) that conspire to greatly increase arrhythmogenesis in HF. The increased NaCaX is unique in contributing to both contractile dysfunction (reducing SR Ca 2ϩ load) and arrhythmogenesis. This novel paradigm provides both a framework and a challenge for further understanding and therapeutic development.
